23 related articles for article (PubMed ID: 14292756)
1. Pirahy virus: Identification of a new and potential emerging arbovirus in South Brazil.
Tschá MK; Suzukawa AA; Rodrigues-Luiz GF; da Silva AM; Cataneo AHD; Mattoso Coelho G; Ferreira AC; Soares Medeiros LC; Mansur D; Zanluca C; Duarte Dos Santos CN
Virus Evol; 2021 Sep; 7(2):veab105. PubMed ID: 35310294
[TBL] [Abstract][Full Text] [Related]
2. Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas.
Forrester NL; Wertheim JO; Dugan VG; Auguste AJ; Lin D; Adams AP; Chen R; Gorchakov R; Leal G; Estrada-Franco JG; Pandya J; Halpin RA; Hari K; Jain R; Stockwell TB; Das SR; Wentworth DE; Smith MD; Kosakovsky Pond SL; Weaver SC
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005693. PubMed ID: 28771475
[TBL] [Abstract][Full Text] [Related]
3. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.
Rülker T; Voß L; Thullier P; O' Brien LM; Pelat T; Perkins SD; Langermann C; Schirrmann T; Dübel S; Marschall HJ; Hust M; Hülseweh B
PLoS One; 2012; 7(5):e37242. PubMed ID: 22666347
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
Vaccine; 2010 Jan; 28(4):1031-40. PubMed ID: 19914193
[TBL] [Abstract][Full Text] [Related]
6. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
[TBL] [Abstract][Full Text] [Related]
8. Epizootiology of Venezuelan equine encephalomyelitis in the Americas.
Walton TE; Johnson KM
J Am Vet Med Assoc; 1972 Dec; 161(11):1509-15. PubMed ID: 4404744
[No Abstract] [Full Text] [Related]
9. TWO HUMAN CASES OF LABORATORY INFECTION WITH MUCAMBO VIRUS.
DEMUCHA MACIAS J; S'ANCHEZ SPINDOLA I
Am J Trop Med Hyg; 1965 May; 14():475-8. PubMed ID: 14292756
[No Abstract] [Full Text] [Related]
10. THE VENEZUELAN EQUINE ENCEPHALOMYELITIS COMPLEX OF GROUP A ARTHROPOD-BORNE VIRUSES, INCLUDING MUCAMBO AND PIXUNA FROM THE AMAZON REGION OF BRAZIL.
SHOPE RE; CAUSEY OR; DE ANDRADE AH
Am J Trop Med Hyg; 1964 Sep; 13():723-7. PubMed ID: 14205893
[No Abstract] [Full Text] [Related]
11. ANTIGENIC VARIATION AMONG STRAINS OF WESTERN EQUINE ENCEPHALOMYELITIS VIRUS.
KARABATSOS N; BOURKE AT; HENDERSON JR
Am J Trop Med Hyg; 1963 May; 12():408-12. PubMed ID: 14044753
[No Abstract] [Full Text] [Related]
12. FACTORS INFLUENCING DETERMINATION OF ANTIGENIC RELATIONSHIPS BETWEEN WESTERN EQUINE ENCEPHALOMYELITIS VIRUS STRAINS.
SATURNO A; HENDERSON JR
J Immunol; 1965 Mar; 94():365-70. PubMed ID: 14279787
[No Abstract] [Full Text] [Related]
13. SEROLOGIC EPIDEMIOLOGY OF WESTERN EQUINE AND ST. LOUIS ENCEPHALITIS VIRUS INFECTION IN CALIFORNIA. II. ANALYSIS OF INAPPARENT INFECTIONS IN RESIDENTS OF AN ENDEMIC AREA.
FROESCHLE JE; REEVES WC
Am J Epidemiol; 1965 Jan; 81():44-51. PubMed ID: 14246080
[No Abstract] [Full Text] [Related]
14. Hemagglutination-inhibition and neutralization tests for the Venezuelan equine encephalomyelitis virus.
SANMARTIN C; DUENAS A
Am J Trop Med Hyg; 1959 May; 8(3):346-8. PubMed ID: 13661536
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
